Valtan-Mepha 40 mg

Valtan-Mepha 40 mg is a medicine authorised by Swissmedic under authorisation number 59513. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 June 2010 and the authorisation is valid without a time limit. ATC code C09CA03 places the medicine in the group Agents acting on the renin-angiotensin system.

  • Dispensing category B
  • Authorisation number 59513
  • ATC C09CA03
  • Synthetic medicines
Authorisation data
Authorisation number59513
NameValtan-Mepha 40 mg
Full nameValtan-Mepha 40 mg, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeC09CA03
First authorisation16 June 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Valtan-Mepha 40 mg, FilmtablettenB16 June 2010
2Valtan-Mepha 80 mg, FilmtablettenB16 June 2010
3Valtan-Mepha 160 mg, FilmtablettenB16 June 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1128Tablette(n)C09CA0302.07.1.B
1228Tablette(n)C09CA0302.07.1.B
1398Tablette(n)C09CA0302.07.1.B
1428Tablette(n)C09CA0302.07.1.B
1598Tablette(n)C09CA0302.07.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Valtan-Mepha 40 mg authorised in Switzerland?

Yes. Valtan-Mepha 40 mg is authorised by Swissmedic under authorisation number 59513, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Valtan-Mepha 40 mg have?

Valtan-Mepha 40 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Valtan-Mepha 40 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com